1-4 of 4
Xavier Ortin
Close
Sort by
Journal Articles

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

Tomas Jose Gonzalez-Lopez, Nuria Bermejo, Rocío Cardesa-Cabrera, Violeta Martínez, Gerardo Aguilar-Monserrate, Gloria Pérez Segura, Abel Domingo García, Josefa Luis-Navarro, Sunil Lakhwani, Natalia Acedo, Maria L Lozano, Silvia Bernat, Ana Torres-Tienza, Ana Ruano, Isidro Jarque, Pilar Galán Alvarez, Carmen Benet Campos, Shally Marcellini-Antonio, Reyes Jimenez-Bárcenas, Daniel Martínez-Carballeira, Dunia de Miguel Llorente, Álvaro Perona Blázquez, Isabel González-Gascón-y-Marín, Elsa Lopez-Ansoar, José María Alonso Alonso, María Luisa Bengochea-Casado, FJ Díaz Gálvez, Ana Moretó, Gemma Moreno, Roberto Hernández-Martin, Erik de Cabo, Julio Davila-Valls, Amalia Cuesta, Carmen Pastoriza Cruz, Gerardo Hermida, Covadonga García, Miguel Angel Pozas-Mañas, Carlos Aguilar-Franco, Dolores Fernandez-Jimenez, Begoña Navas-Elorza, Carolina López-Santamaría Castro, Alvaro Lorenzo Vizcaya, Xavier Ortín, Marta garcia pintos, Sonia Piernas, Johana Díaz-Santa, Inmaculada Soto-Ortega, Dr, Drew Provan, Gloria García-Donas Gabaldón
Journal: Blood
Blood blood.2024024250.
https://doi.org/10.1182/blood.2024024250
Published: 2024
Journal Articles

Prospective Population-Based Analysis of Characteristics and Therapy Options in AML: The Case of Catalonia (PERIS Project)

Montserrat Hoyos, Ana Garrido, Montserrat Arnan, MD, Marina Diaz-Beyá, MD, Olga Salamero, MD, Susana Vives, MD, Antonio Garcia-Guiñon, MD, David Gallardo, MD, Marta Cervera, MD, Ferran Vall-Llovera, MD, Cristina Motlló, Brayan Merchan, MD, Imma Roig Martinez, Xavier Ortin, Pável E Olivera, MD, Anna Sureda Balari, MD PhD, David Valcarcel, Josep-Maria Ribera, Jordi Esteve, Jorge Sierra, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-139160
Published: 2020
Journal Articles

Risk-Adapted Intensive Chemotherapy for Primary ACUTE Myeloid Leukemia during the Last 25 YEARS: Increase in Complete Remission RATE, Hematopoietic Cell Transplantation Access and Decrease in Relapse Incidence Have LED to Improved Survival

Ana Garrido, Montserrat Hoyos, Marina Diaz-Beyá, MD, Montserrat Arnan, MD, Susana Vives, MD, Marisa Calabuig, MD, Olga Salamero, MD, David Gallardo, MD, Maria Paz Queipo De Llano, MD, Lourdes Escoda, MD, Antonia Sampol, MD, Ferran Vall-Llovera, MD, Antonio Garcia-Guiñon, MD, Merchan Brayan, MD, Joan Bargay, MD, J Pio Torres, Xavier Ortin, M Luz Amigo, Jose Maria Moraleda, MD PhD, José F. Falantes, David Valcarcel, Mar Tormo, MD, Josep-Maria Ribera, Salut Brunet, MD, Anna Sureda Balari, MD PhD, Jordi Esteve, Jorge Sierra, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-140680
Published: 2020
Journal Articles

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

Jorge Sierra, MD, Ana Garrido, Marina Diaz Beya, MD, Montserrat Hoyos, Marisa Calabuig, MD, Susana Vives, MD, Montserrat Arnan Sangerman, MD PhD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Ferran Vall-Llovera, MD, Alex Bataller, Francisca Guijarro, MD, Lourdes Escoda, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD MSc, Xavier Ortin, Isabel Sanchez Ortega, MD PhD, Marta Pratcorona, MD PhD, Joan Bargay, MD PhD, Antonia Sampol, Josep Nomdedeu, MD PhD, David Gallardo, Josep-Maria Ribera, MD PhD, Mar Tormo, Jordi Esteve, Salut Brunet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 289.
https://doi.org/10.1182/blood-2019-128682
Published: 2019